Aminoglycoside use in intensive care units and aminoglycoside nephrotoxicity. Comment letter 1
- PMID: 20479210
- PMCID: PMC2876408
- DOI: 10.1128/AAC.00892-09
Aminoglycoside use in intensive care units and aminoglycoside nephrotoxicity. Comment letter 1
Comment on
-
Prevalence and risk factors for aminoglycoside nephrotoxicity in intensive care units.Antimicrob Agents Chemother. 2009 Jul;53(7):2887-91. doi: 10.1128/AAC.01430-08. Epub 2009 Apr 13. Antimicrob Agents Chemother. 2009. PMID: 19364846 Free PMC article.
References
-
- Beardsley, J. R., J. C. Williamson, J. W. Johnson, C. A. Ohl, T. B. Karchmer, and D. L. Bowton. 2006. Using local microbiologic data to develop institution-specific guidelines for the treatment of hospital-acquired pneumonia. Chest 130:787-793. - PubMed
-
- Bhat, S., S. Fujitani, B. A. Potoski, B. Capitano, P. K. Linden, K. Shutt, and D. L. Paterson. 2007. Pseudomonas aeruginosa infections in the Intensive Care Unit: can the adequacy of empirical beta-lactam antibiotic therapy be improved? Int. J. Antimicrob. Agents 30:458-462. - PubMed
-
- Drusano, G. L., P. G. Ambrose, S. M. Bhavnani, J. S. Bertino, A. N. Nafziger, and A. Louie. 2007. Back to the future: using aminoglycosides again and how to dose them optimally. Clin. Infect. Dis. 45:753-760. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
